Fig. 1

Revised Tarlov scores. Motor function outcome at 7 days after MPSS and AD-MSCs administration. The AD-MSCs group had significantly enhanced motor function compared with the control group at 7 days post treatment. × mean. *P <0.05 compared with the control group. AD-MSCs adipose-derived mesenchymal stem cells, MPSS methylprednisolone sodium succinate